Clinical trial • Phase II • Psychiatry

LY03010 for Schizophrenia

Phase II trial of LY03010 for Schizophrenia.

Overview

Trial Therapeutic Area
Psychiatry
Trial Disease
Schizophrenia
Trial Stage
Phase II
Drug Modality
Small molecule

Key dates

Initial CTIS Submission Date
24-11-2023
First CTIS Authorization Date
04-04-2024

Trial design

Randomised, open-label, ly03010 versus xeplion®; dose and schedule not specified in the available record-controlled Phase II trial in Bulgaria, Portugal, Croatia.

Randomised
Yes
Open Label
Yes
Comparator
LY03010 versus XEPLION®; dose and schedule not specified in the available record
Target Sample Size
158

Recruitment

Planned Sample Size
158
Recruitment Window Months
16

Geography

Total Number Of Sites
19
Total Number Of Participants
170

Bulgaria

Earliest CTIS Part Ii Submission Date
28-03-2024
Latest Decision Or Authorization Date
08-04-2024
Processing Time Days
11
Number Of Sites
12
Number Of Participants
85

Sites

Site Name
Center For Mental Health Vratsa EOOD
Department Name
psychiatry
Contact Person Name
Nadya Ivanova
Contact Person Email
nadia_odpzs@abv.bg
Site Name
MENTAL HEALTH CENTER PROF. DR. IVAN TEMKOV
Department Name
psychiatry
Contact Person Name
Veselin Palazov
Contact Person Email
vPalazov@abv.bg
Site Name
"Multiprofile Hospital for Active Treatment Dr. Hristo Stambolski"
Department Name
psychiatry
Contact Person Name
Ivan Todorov Dimitrov
Contact Person Email
itdim@abv.bg
Site Name
Outpatient Clinic For Specialized Medical Care-Individual Practice For Specialized Medical Care-Psychiatry Dr. Georgi Hranov
Department Name
psychiatry
Contact Person Name
Georgi Hranov
Contact Person Email
hranov@gmail.com
Site Name
Center For Skin And Venereal Diseases Veliko Tarnovo EOOD
Department Name
psychiatry
Contact Person Name
Nikitov Ognyan Nikolaev
Contact Person Email
o.nikitov@gmail.com
Site Name
Diagnostics-Consultancy Center Mladost M Varna OOD
Department Name
psychiatry
Contact Person Name
Hristo Vasilev Kozhuharov
Contact Person Email
christokojuharov@abv.bg
Site Name
University Multiprofile Hospital For Active Treatment Dr. Georgi Stranski EAD
Department Name
psychiatry
Contact Person Name
Maya Yordanova Stoimenova-Popova
Contact Person Email
dr.maya.stoimenova@gmail.com
Site Name
MBAL Dr. Ivan Seliminski - Sliven AD
Department Name
psychiatry
Contact Person Name
Rozalina Petrova
Contact Person Email
dr.rozalina.petrova@gmail.com
Site Name
Higya–DCC OOD
Department Name
psychiatry
Contact Person Name
Dora Atanasova
Contact Person Email
dora_pazardjik@abv.bg
Site Name
Multiprofile Hospital For Active Treatment - Targovishte AD
Department Name
psychiatry
Contact Person Name
Veselka Vasileva
Contact Person Email
vesi_vasileva2002@yahoo.com
Site Name
State Psychiatric Hospital Tsarev Brod
Department Name
psychiatry
Contact Person Name
Neli Todorova
Contact Person Email
nelly_nik@abv.bg
Site Name
Alexandrovska University Hospital
Department Name
psychiatry
Contact Person Name
Vihra Milanova
Contact Person Email
vihra.milanova@gmail.com

Portugal

Earliest CTIS Part Ii Submission Date
07-02-2024
Latest Decision Or Authorization Date
05-04-2024
Processing Time Days
58
Number Of Sites
4
Number Of Participants
56

Sites

Site Name
Centro Hospitalar De Vila Nova De Gaia/Espinho E.P.E.
Department Name
Psychiatry and Mental Health Service
Contact Person Name
Georgina Lapa
Contact Person Email
glapa@chvng.min-saude.pt
Site Name
CCAB Centro Clinico Academico Braga Associacao
Department Name
Psychiatry Service
Contact Person Name
Pedro Morgado
Contact Person Email
pedromorgado@med.uminho.pt
Site Name
Hospitais Senhor Do Bonfim S.A.
Department Name
Neurosciences
Contact Person Name
Jacinto Azevedo
Contact Person Email
jacinto.azevedo@trofasaude.com
Site Name
Centro Hospitalar De Leiria E.P.E.
Department Name
Psychiatry
Contact Person Name
Ana Fonseca

Croatia

Earliest CTIS Part Ii Submission Date
28-03-2024
Latest Decision Or Authorization Date
27-08-2024
Processing Time Days
152
Number Of Sites
3
Number Of Participants
29

Sites

Site Name
Clinic for psychiatry Sveti Ivan
Department Name
psychiatry
Contact Person Name
Igor Filipcic
Contact Person Email
igor.filipcic@pbsvi.hr
Site Name
KBC Split
Department Name
psychiatry
Contact Person Name
Trpimir Glavina
Contact Person Email
office@kbsplit.hr
Site Name
Klinika za psihijatriju Vrapce
Department Name
psychiatry
Contact Person Name
Miroslav Herceg

Sponsor

Primary sponsor

Full Name
Geneora Pharma (Shijiazhuang) Co. Ltd.
Organisation Type
Pharmaceutical company
Country Of Registered Address
China

Investigational products

Investigational Product Name
LY03010
Modality
Small molecule
Investigational Product Name
XEPLION®
Modality
Small molecule

Related trials

Other published trials that may interest you.